Your trusted destination for CME, CPD & Medical Education across the Middle East.
Join the 10th MENACTRIMS Congress in Dubai, a premier event for neurologists and healthcare professionals to explore the latest advancements in Multiple Sclerosis research, diagnosis, and treatment through expert-led sessions and symposia.
The 10th MENACTRIMS Congress serves as a premier platform for excellence in education and research related to multiple sclerosis (MS). This two-day event, organized by Lumina Organizers, will feature cutting-edge presentations from distinguished international and regional keynote speakers. Attendees will gain insights into the latest advancements in MS treatments, clinical research, therapeutic approaches, pathology, imaging, and diagnosis. The program includes plenary sessions, scientific symposia, and specialized parallel sessions for nurses, organized in partnership with the IOMSN and CMSC, with a scientific symposium contributed by the European Charcot Foundation.
Exploring the use of high-resolution MRI and other cutting-edge imaging modalities for more accurate diagnosis and monitoring of MS progression.
Discussion on the latest research and clinical application of biomarkers for diagnosis, prognosis, and treatment response in Multiple Sclerosis.
Strategies for distinguishing MS from other neurological conditions, including NMOSD and MOGAD.
An overview of current and emerging DMTs, their mechanisms of action, and their role in slowing disease progression.
Focus on the latest research and treatment approaches specifically for primary and secondary progressive forms of MS.
Exploring new therapeutic targets and the advancements in immunotherapy for managing Multiple Sclerosis.
Understanding the importance and integration of patient-reported outcomes in clinical practice and research to enhance quality of life.
Examining the role of physical therapy, lifestyle changes, and mental health management in the holistic care of MS patients.
Reviewing best practices and latest guidelines for managing common MS symptoms and treating acute relapses.
Updates on the diagnosis, pathology, and treatment of Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Insights into the impact of genetic predispositions and environmental triggers on MS pathogenesis and risk assessment.
A session dedicated to the most recent breakthroughs, ongoing clinical trials, and future directions in MS research.
Accreditation is being sought from the Department of Health- Abu Dhabi (DoH) for this congress.
Attendees are eligible to receive up to 12 CPD credits for their participation in the event.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow